ArticleOrthopaedic journal of sports medicine2026
Structural Gains Without Symptomatic Benefit After Microfracture During High Tibial Osteotomy.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High tibial osteotomy (HTO) realigns the mechanical axis and reduces medial compartment overload in knee osteoarthritis. Microfracture (MFx) is often added to stimulate cartilage repair, yet whether MFx provides additional clinical benefit in the degenerative osteoarthritic environment remains uncertain. Emerging evidence suggests that structural cartilage changes do not consistently correlate with symptoms, raising the possibility of structure-symptom discordance. Purpose/Hypothesis: The purpose of this study was to evaluate whether MFx performed during HTO improves cartilage regeneration and postoperative patient-reported outcomes and to determine whether structural improvement corresponds with symptomatic benefit. It was hypothesized that MFx would enhance cartilage regeneration and lead to superior clinical outcomes compared with HTO alone. Study Design: Cohort study; Level of evidence 3. Methods: A total of 62 patients who underwent navigation-assisted medial opening-wedge HTO with second-look arthroscopy at 2 years were included. Patients were categorized into 2 groups: HTO alone (group 1; n = 30) and HTO with MFx for well-shouldered focal defects (group 2; n = 32). Cartilage status was graded using the International Cartilage Regeneration & Joint Preservation Society (ICRS) system, and improvement was defined as a decrease in grade. Clinical outcomes were assessed at 2 years using the International Knee Documentation Committee (IKDC) subjective score. Group comparisons, correlation analyses, and multivariable linear regression were performed to determine independent predictors of postoperative IKDC score. Results: Cartilage improvement occurred in 33.3% of group 1 and 62.5% of group 2 ( Conclusion: MFx performed during HTO improved cartilage morphology but did not yield superior clinical outcomes. MFx was associated with significantly lower adjusted IKDC scores, and structural improvement did not correlate with symptomatic benefit.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.